PortfoliosLab logoPortfoliosLab logo
CII vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CII vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BlackRock Enhanced Large Cap Core Fund (CII) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CII achieves a 7.72% return, which is significantly higher than ABBV's 1.30% return. Over the past 10 years, CII has underperformed ABBV with an annualized return of 14.94%, while ABBV has yielded a comparatively higher 19.10% annualized return.


CII

1D
0.58%
1M
-1.09%
YTD
7.72%
6M
10.66%
1Y
39.37%
3Y*
20.94%
5Y*
13.51%
10Y*
14.94%

ABBV

1D
1.32%
1M
8.24%
YTD
1.30%
6M
3.65%
1Y
23.06%
3Y*
22.39%
5Y*
18.94%
10Y*
19.10%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CII vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CII
BlackRock Enhanced Large Cap Core Fund
7.72%37.78%12.70%18.47%-13.21%34.26%8.11%30.46%-8.60%27.73%
ABBV
AbbVie Inc.
1.30%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between CII and ABBV is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.31

Over the past year, the correlation between CII and ABBV has dropped to 0.05 - well below their long-term average of 0.31, suggesting their price drivers have been diverging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CII vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CII
CII Risk / Return Rank: 8484
Overall Rank
CII Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
CII Sortino Ratio Rank: 8383
Sortino Ratio Rank
CII Omega Ratio Rank: 8080
Omega Ratio Rank
CII Calmar Ratio Rank: 8484
Calmar Ratio Rank
CII Martin Ratio Rank: 8484
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 6868
Overall Rank
ABBV Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 6666
Sortino Ratio Rank
ABBV Omega Ratio Rank: 6565
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6868
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CII vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BlackRock Enhanced Large Cap Core Fund (CII) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CIIABBVDifference
Sharpe ratioReturn per unit of total volatility

+1.61

Sortino ratioReturn per unit of downside risk

+1.92

Omega ratioGain probability vs. loss probability

1.43

1.18

+0.25

Calmar ratioReturn relative to maximum drawdown

3.33

1.29

+2.04

Martin ratioReturn relative to average drawdown

12.71

2.88

+9.84

CII vs. ABBV - Sharpe Ratio Comparison

The current CII Sharpe Ratio is 2.52, which is higher than the ABBV Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of CII and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CII vs. ABBV - Drawdown Comparison

The maximum CII drawdown since its inception was -56.43%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for CII and ABBV.


Loading charts...

Drawdown Indicators


CIIABBVDifference

Max Drawdown

Largest peak-to-trough decline

-56.43%

-45.09%

-11.34%

Max Drawdown (1Y)

Largest decline over 1 year

-11.67%

-17.32%

+5.65%

Max Drawdown (3Y)

Largest decline over 3 years

-21.05%

-20.74%

-0.31%

Max Drawdown (5Y)

Largest decline over 5 years

-22.32%

-21.92%

-0.40%

Max Drawdown (10Y)

Largest decline over 10 years

-40.56%

-45.09%

+4.53%

Current Drawdown

Current decline from peak

-6.33%

-4.60%

-1.73%

Average Drawdown

Average peak-to-trough decline

-6.17%

-10.71%

+4.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.05%

7.75%

-4.70%

Volatility

CII vs. ABBV - Volatility Comparison

The current volatility for BlackRock Enhanced Large Cap Core Fund (CII) is 5.22%, while AbbVie Inc. (ABBV) has a volatility of 6.10%. This indicates that CII experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CIIABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.22%

6.10%

-0.88%

Volatility (6M)

Calculated over the trailing 6-month period

12.09%

17.85%

-5.76%

Volatility (1Y)

Calculated over the trailing 1-year period

15.40%

24.31%

-8.91%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.16%

22.89%

-5.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.54%

25.73%

-7.19%

Dividends

CII vs. ABBV - Dividend Comparison

CII's dividend yield for the trailing twelve months is around 15.93%, more than ABBV's 2.96% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.96%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
CII
BlackRock Enhanced Large Cap Core Fund
15.35%16.65%6.15%6.28%12.27%4.98%6.03%5.79%7.06%6.07%8.38%8.49%

Frequently Asked Questions


CII and ABBV have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABBV has higher volatility (6.10%) compared to CII (5.22%). In terms of maximum drawdown, CII dropped -56.43% vs ABBV's -45.09%.

CII currently has the higher Sharpe Ratio (2.52 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CII and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer